The Cost Barrier: Why Your Patients Need Help Affording Rectiv

As a provider who prescribes Rectiv (nitroglycerin 0.4% ointment) for chronic anal fissures, you already know it's an effective first-line topical treatment. What you may underestimate is how often cost prevents your patients from actually filling the prescription.

At $500 to $900+ per 30g tube without insurance — and with no FDA-approved generic available as of 2026 — Rectiv is one of the more expensive prescriptions for a relatively short treatment course. Even insured patients may face high copays, prior authorization requirements, or outright denials.

The result? Patients leave your office with a prescription they can't afford, and their chronic anal fissure remains untreated. This guide covers every strategy available to help your patients access Rectiv affordably — or find a suitable alternative when cost is prohibitive.

Understanding the Insurance Landscape for Rectiv

Common Insurance Barriers

When your patient takes a Rectiv prescription to the pharmacy, they may encounter:

• Prior authorization required: Many commercial and Medicare Part D plans require PA for Rectiv due to its cost and niche indication
• Step therapy: Some plans require documentation that conservative treatments (fiber, sitz baths, stool softeners) have failed before approving Rectiv
• Tier 3 or specialty tier placement: Even when covered, Rectiv is often on a high copay tier ($75-$200+ copay)
• Not on formulary: Some plans don't cover Rectiv at all

Prior Authorization Best Practices

To improve PA approval rates for Rectiv:

1. Document conservative treatment failure. Note in your chart (and PA submission) that the patient has tried and failed conservative measures — dietary fiber supplementation, stool softeners, sitz baths, and topical analgesics — for an adequate duration (typically 4-8 weeks).
2. Include the diagnosis with ICD-10 code. Use K60.1 (chronic anal fissure) or K60.2 (anal fissure, unspecified) as appropriate. Chronic designation strengthens the medical necessity argument.
3. Note that Rectiv is the only FDA-approved topical treatment for this indication. This is a powerful argument — there is no generic equivalent or FDA-approved therapeutic alternative in this formulation.
4. Document impact on quality of life. Include the patient's pain severity, functional limitations, and why surgical intervention is not yet appropriate or desired.
5. Submit peer-to-peer review if initially denied. Speak with the plan's medical director directly. The single-source, FDA-approved status of Rectiv is compelling in peer review.

Appealing Insurance Denials

If the PA is denied:

• Review the specific denial reason and address it directly in the appeal
• Include supporting clinical literature on nitroglycerin ointment efficacy for chronic anal fissures
• Reference FDA approval and the lack of generic alternatives
• Consider involving the patient — patient appeals (especially for employer-sponsored plans) can sometimes move faster than provider-initiated appeals

For a broader look at the availability challenges your patients face, see our provider guide on Rectiv shortage information for prescribers.

Prescription Discount Cards and Coupon Programs

For patients paying cash — or whose insurance copay is high — prescription discount cards can reduce the out-of-pocket cost of Rectiv. While savings vary and may not bring Rectiv to an affordable level for all patients, they're worth exploring.

Major Discount Card Options

• GoodRx (goodrx.com) — widely accepted, shows pricing at multiple pharmacies
• SingleCare (singlecare.com) — sometimes offers better pricing than GoodRx for specific pharmacies
• RxSaver (rxsaver.com) — compares prices across local pharmacies
• Optum Perks (perks.optum.com) — another comparison tool with downloadable discount cards
• BuzzRx (buzzrx.com) — free discount card program

Instruct your patients to compare prices across multiple cards and pharmacies, as pricing can vary significantly. These cards cannot be combined with insurance — they're an alternative payment method, typically used when cash price with the discount is lower than the insurance copay.

Important Note on Discount Cards

Discount card prices for Rectiv may still be several hundred dollars. Set realistic expectations with patients. If the discounted price is still unaffordable, proceed to compounding alternatives (discussed below).

Patient Assistance Programs (PAPs)

For uninsured or financially struggling patients, manufacturer and independent patient assistance programs may help:

Manufacturer Programs

Rectiv is manufactured by Allergan, now part of AbbVie. AbbVie operates patient assistance programs for some of its medications. Contact AbbVie's patient support line or visit their website to check current Rectiv eligibility. Criteria typically include:

• U.S. residency
• No insurance coverage or inadequate coverage for the medication
• Income below a specified threshold (often 300-400% of the federal poverty level)

Independent Assistance Programs

• NeedyMeds (needymeds.org) — database of patient assistance programs searchable by drug name
• RxAssist (rxassist.org) — comprehensive directory of assistance programs
• RxHope (rxhope.com) — helps connect patients to manufacturer programs

Your office staff can help patients navigate these programs. Consider creating a workflow where your MA or patient navigator initiates the PAP application when Rectiv is prescribed to an uninsured or underinsured patient.

Compounded Nitroglycerin Ointment: The Most Practical Alternative

For many patients, the most cost-effective solution isn't brand-name Rectiv at all — it's compounded nitroglycerin ointment from a compounding pharmacy.

How Compounding Works

Compounding pharmacies can prepare nitroglycerin ointment in various concentrations (typically 0.2-0.4%) for $30 to $100 — a fraction of Rectiv's cost. While compounded medications are not FDA-approved (they don't undergo the same regulatory review as manufactured products), nitroglycerin ointment for anal fissures has extensive clinical evidence supporting its use.

Prescribing Compounded Nitroglycerin

To prescribe compounded nitroglycerin ointment:

1. Write the prescription for: Nitroglycerin 0.2% or 0.4% ointment (rectal), 30g, Apply 1 inch intra-anally every 12 hours for 3 weeks
2. Send to a compounding pharmacy. Not all pharmacies compound — you'll need to identify compounding pharmacies in your area or use a national mail-order compounding pharmacy.
3. Discuss concentration with the patient. 0.2% may have fewer headache side effects but potentially lower efficacy. 0.4% matches the FDA-approved Rectiv concentration. Many providers start at 0.2% and increase if needed.

When to Use Brand Rectiv vs. Compounded

For most cost-sensitive patients, compounded nitroglycerin is the pragmatic choice. Reserve brand Rectiv for patients who have insurance coverage, those who prefer an FDA-approved product, or when a compounding pharmacy isn't accessible.

For a patient-facing version of this information, see our guide on alternatives to Rectiv.

Helping Patients Navigate Availability Issues

Beyond cost, your patients may struggle to find Rectiv in stock due to ongoing supply challenges. Here's how you can help:

• Recommend MedFinder — direct patients to medfinder.com to check real-time pharmacy availability before they start calling around
• Build pharmacy relationships. Identify 2-3 pharmacies in your area that reliably stock Rectiv and note them in your practice's resource list
• Send prescriptions strategically. If you know a specific pharmacy has Rectiv, send the prescription there rather than to the patient's usual pharmacy
• Have a compounding backup plan. Keep a compounding pharmacy referral ready for when brand Rectiv is unavailable

For detailed guidance on helping patients locate Rectiv, see our provider guide on how to help your patients find Rectiv in stock.

Creating a Cost Conversation Workflow

Consider implementing a standardized workflow for Rectiv prescriptions:

1. At the time of prescribing: Discuss cost upfront. Ask if the patient has concerns about affordability.
2. Check insurance coverage: Have staff verify coverage and PA requirements before the patient leaves.
3. Initiate PA if needed: Start the prior authorization process the same day to minimize delays.
4. Provide alternatives: If insurance won't cover Rectiv, have the compounding pharmacy option ready.
5. Share resources: Give patients information about discount cards, PAPs, and MedFinder.

This proactive approach reduces prescription abandonment and ensures your patients actually receive treatment for their chronic anal fissures.

Key Takeaways for Providers

• Rectiv costs $500-$900+ without insurance — cost is a major barrier to treatment adherence
• Prior authorization is often required; document conservative treatment failure and Rectiv's unique FDA-approved status
• Compounded nitroglycerin ointment ($30-$100) is the most practical cost alternative for uninsured/underinsured patients
• Prescription discount cards (GoodRx, SingleCare, etc.) can reduce cash prices but may still be significant
• Patient assistance programs through AbbVie and independent organizations may help qualifying patients
• Direct patients to MedFinder for real-time Rectiv availability checking
• Build a standardized workflow so cost conversations happen at the point of prescribing, not at the pharmacy counter